The rationale for the use of drugs in the treatment of diabetes mellitus.
D000284:Administration, Oral; D001645:Biguanides / Q000009:adverse effects / Q000627:therapeutic use; D001786:Blood Glucose / Q000032:analysis; D003920:Diabetes Mellitus / Q000175:diagnosis / Q000188:drug therapy* / Q000628:therapy; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy; D003926:Diabetic Coma / Q000188:drug therapy / Q000209:etiology; D016883:Diabetic Ketoacidosis / Q000188:drug therapy; D004035:Diet Therapy; D005223:Fats / Q000096:biosynthesis; D006801:Humans; D006946:Hyperinsulinism / Q000209:etiology / Q000628:therapy; D007267:Injections; D007328:Insulin / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D007651:Keto Acids; D009765:Obesity; D013453:Sulfonylurea Compounds / Q000009:adverse effects / Q000627:therapeutic use
D001645:Biguanides; D001786:Blood Glucose; D005223:Fats; D007328:Insulin; D007651:Keto Acids; D013453:Sulfonylurea Compounds